Evvy raises $40M as it seeks to further women’s health research with vaginal microbiome data

Automated excerpt

Women’s health company Evvy on Tuesday said it has raised a $40 million Series B led by Catalio Capital Management. She added that clinicians on Evvy can now leverage the collected data to offer personalized treatment to patients. Besides Evvy, others in the vaginal health space include JunoBio, TinyHealth, and Daye.

Selected automatically from source text; not independently written or fact-checked. Read the original for full context.